Implementing Innovations in Alzheimer’s Diagnostic Testing and Treatment

Alzheimer’s care is entering a new era — one where diagnosis is no longer limited to late-stage symptoms, and where early detection may open the door to better planning, timely referrals, and emerging treatment possibilities. In this episode, we explore the changing landscape of Alzheimer’s diagnostic testing and treatment, with a focus on blood-based biomarkers, cognitive assessments, primary care workflows, specialist referrals, and the evolving role of brain health navigator models. The conversation looks at how family physicians and neurologists can work together to identify cognitive changes earlier, evaluate addressable causes, and guide patients through shared decision-making with greater clarity and confidence. A thoughtful discussion on memory, medicine, innovation and the future of Alzheimer’s care.